In this study, we used the recently reported TPA particles characterized by enhanced gene expression, high titer production, and large DNA sequence accommodation,9 then constructed the RGD4C.TPA.TNFα (Figure 1) to evaluate the efficacy of guided systemic delivery of TNFα gene for medulloblastoma treatment. This evidence concerns the gene PLAT and medulloblastoma.